Navigation Links
India Pharmaceutical Sector Reviewed by Kelly Scientific Publications in In-demand Report Now Available at MarketPublishers.com
Date:7/31/2013

London, UK (PRWEB) July 31, 2013

India’s pharmaceutical market has experienced unprecedented growth recently to currently stand at USD 11 billion in value. The robust growth of the sector is spurred to a large extent by rising domestic consumption levels in tandem with the increasing demand from export markets. The national pharmaceutical industry has also seen a considerable breakthrough in the infrastructure development, science and technology base, as well as the introduction of new products into the market.

Pharmaceutical sales in India are anticipated to go beyond USD 73.9 billion by end-2020. Over the next decade, the country is likely to turn into a significant player in the worldwide pharmaceutical arena and become a major hub for all pharmaceutical research and manufacturing needs.

In-demand research study “Pharmaceutical Market: India, A Competitive Industry Analysis” worked out by Kelly Scientific Publications has been recently published by Market Publishers Ltd.

Report Details:

Title: Pharmaceutical Market: India, A Competitive Industry Analysis
Published: May, 2013
Pages:    161
Price:    US$ 2,600.00
http://marketpublishers.com/report/life_sciences/pharmaceuticals/pharmaceutical-market-india-a-competitive-industry-analysis.html    

The report provides a comprehensive analysis of the Indian pharmaceutical market. It contains critical information on the market size and segmentation; presents insightful market assessment by segment, therapeutic area, disease category and company; includes a SWOT analysis. The research study characterizes the regulative framework and business environment in the country; unveils qualitative and quantitative data on the market performance; identifies major factors driving the market and outlines key industry opportunities and challenges. The report delves into the competitive landscape, profiles the leading market participants and gives details on their operations, products, financials and business strategy. Moreover, the report discusses future prospects of the Indian pharma industry.

Report Scope:

  •     Epidemiology and disease overview.
  •     Twelfth five year plan – a boost for scientific research and development.
  •     Description of the economic and business environment.
  •     In-depth analysis of the Indian pharmaceutical market.
  •     Critical data on the market performance.
  •     Indian pharmaceutical company profiles and financial data.
  •     Clear picture of the competitive scenario.
  •     SWOT analysis.
  •     Comprehensive market assessment by disease category, therapeutic area, segment and company.
  •     Industry future outlook through 2017.

More research studies by the publisher can be found at Kelly Scientific Publications page.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10983654.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Nanounity Announces New Characterization Tools for the 2013 Microscopy & Microanalysis Annual Meeting in Indianapolis, August 4-8
2. Navigating the Dynamic Indian Clinical Trial Landscape, New Webinar Hosted by Xtalks
3. StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500
4. Nutra Pharma Patent and Trademarks Published in India
5. Indigo Biosystems Among “Best Places to Work” in Indiana
6. Infectious Immunology Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
7. Indiana’s Life Sciences Industry Economic Impact Tops $50 billion
8. Atharva Lifesciences Consulting Releases the Biggest Ever Compilation of Science Funding Sources for India
9. Webinar to Discuss Biosimilar Regulatory Guidelines in India and Emerging Markets
10. SAHYOG: Future of Bio-based Economy in India and European Union
11. Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018: China Market Research Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... June 23, 2016  The Prostate Cancer Foundation (PCF) is pleased ... and faster cures for prostate cancer. Members of the Class of 2016 were ... Read More About the Class of 2016 PCF Young ... ... ...
(Date:6/23/2016)... ... 2016 , ... STACS DNA Inc., the sample tracking software company, today announced ... has joined STACS DNA as a Field Application Specialist. , “I am thrilled ... COO of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
Breaking Biology Technology:
(Date:4/19/2016)... April 20, 2016 The new ... a compact web-based "all-in-one" system solution for all door ... reader or the door interface with integration authorization management ... control systems. The minimal dimensions of the access control ... the building installations offer considerable freedom of design with ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):